Linda Baddour, Chief Financial Officer at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 17,000 shares at $34.17 ($582K) on 2007-02-09, disclosed to the SEC on 2007-02-12.
Open-market sale of $582k PPDI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.15 | 1,900 | $65K | 11.1% |
| 2 | $34.17 | 400 | $14K | 2.3% |
| 3 | $34.18 | 998 | $34K | 5.9% |
| 4 | $34.19 | 1,300 | $44K | 7.6% |
| 5 | $34.20 | 702 | $24K | 4.1% |
| 6 | $34.21 | 700 |
| $24K |
| 4.1% |
| 7 | $34.22 | 500 | $17K | 2.9% |
| 8 | $34.25 | 1,500 | $51K | 8.8% |
| 9 | $34.26 | 800 | $27K | 4.7% |
| 10 | $34.27 | 1,100 | $38K | 6.5% |
| 11 | $34.28 | 900 | $31K | 5.3% |
| 12 | $34.29 | 100 | $3K | 0.6% |
| 13 | $34.30 | 2,800 | $96K | 16.5% |
| 14 | $34.31 | 1,000 | $34K | 5.9% |
| 15 | $34.33 | 100 | $3K | 0.6% |
| 16 | $34.34 | 100 | $3K | 0.6% |
| 17 | $34.35 | 500 | $17K | 2.9% |
| 18 | $34.36 | 300 | $10K | 1.8% |
| 19 | $34.37 | 1,200 | $41K | 7.1% |
| 20 | $34.38 | 100 | $3K | 0.6% |
| Total | $34.25 avg | 17,000 | $582K | 100% |
| Filing → |
| WAT | SELL | 2021-05-14 | $787K | — | Filing → |
| PRAH | SELL | 2018-01-18 | $12.1M | — | Filing → |
| PRAH | SELL | 2017-08-16 | $15.0M | — | Filing → |